ID   ROA2_RAT                Reviewed;         353 AA.
AC   A7VJC2; A7VJC1; A7VJC3; A7VJC4;
DT   03-MAR-2009, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 1.
DT   29-MAY-2024, entry version 121.
DE   RecName: Full=Heterogeneous nuclear ribonucleoproteins A2/B1 {ECO:0000312|EMBL:BAF79676.1};
DE            Short=hnRNP A2/B1;
GN   Name=Hnrnpa2b1 {ECO:0000250|UniProtKB:P22626};
GN   Synonyms=Hnrnp {ECO:0000312|EMBL:BAF79676.1},
GN   Hnrpa2b1 {ECO:0000250|UniProtKB:P22626};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A2; B1; A2B AND B1B), SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9925756; DOI=10.1006/excr.1998.4323;
RA   Kamma H., Horiguchi H., Wan L., Matsui M., Fuiwara M., Fujimoto M.,
RA   Yazawa T., Dreyfuss G.;
RT   "Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific
RT   expression and novel isoforms.";
RL   Exp. Cell Res. 246:399-411(1999).
RN   [2]
RP   PROTEIN SEQUENCE OF 100-113; 116-137 AND 2014-226, FUNCTION, RNA-BINDING,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=9578590; DOI=10.1021/bi9800247;
RA   Hoek K.S., Kidd G.J., Carson J.H., Smith R.;
RT   "hnRNP A2 selectively binds the cytoplasmic transport sequence of myelin
RT   basic protein mRNA.";
RL   Biochemistry 37:7021-7029(1998).
RN   [3]
RP   FUNCTION, AND RNA-BINDING.
RX   PubMed=10567417; DOI=10.1074/jbc.274.48.34389;
RA   Munro T.P., Magee R.J., Kidd G.J., Carson J.H., Barbarese E., Smith L.M.,
RA   Smith R.;
RT   "Mutational analysis of a heterogeneous nuclear ribonucleoprotein A2
RT   response element for RNA trafficking.";
RL   J. Biol. Chem. 274:34389-34395(1999).
RN   [4]
RP   METHYLATION.
RX   PubMed=10772824; DOI=10.1006/excr.2000.4827;
RA   Nichols R.C., Wang X.W., Tang J., Hamilton B.J., High F.A., Herschman H.R.,
RA   Rigby W.F.;
RT   "The RGG domain in hnRNP A2 affects subcellular localization.";
RL   Exp. Cell Res. 256:522-532(2000).
RN   [5]
RP   FUNCTION.
RX   PubMed=15659580; DOI=10.1093/nar/gki203;
RA   Moran-Jones K., Wayman L., Kennedy D.D., Reddel R.R., Sara S., Snee M.J.,
RA   Smith R.;
RT   "hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere.";
RL   Nucleic Acids Res. 33:486-496(2005).
RN   [6]
RP   REVIEW.
RX   PubMed=19099192; DOI=10.1007/s00018-008-8532-1;
RA   He Y., Smith R.;
RT   "Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B.";
RL   Cell. Mol. Life Sci. 66:1239-1256(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=19343716; DOI=10.1002/pmic.200800664;
RA   Maurya D.K., Sundaram C.S., Bhargava P.;
RT   "Proteome profile of the mature rat olfactory bulb.";
RL   Proteomics 9:2593-2599(2009).
RN   [8]
RP   SUBCELLULAR LOCATION (ISOFORMS B1; A2; A2B AND B1B).
RX   PubMed=20406423; DOI=10.1111/j.1600-0854.2010.01072.x;
RA   Han S.P., Friend L.R., Carson J.H., Korza G., Barbarese E., Maggipinto M.,
RA   Hatfield J.T., Rothnagel J.A., Smith R.;
RT   "Differential subcellular distributions and trafficking functions of hnRNP
RT   A2/B1 spliceoforms.";
RL   Traffic 11:886-898(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-212; SER-259 AND SER-344, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [10]
RP   ACETYLATION AT MET-1, METHYLATION AT ARG-266, SUBCELLULAR LOCATION (ISOFORM
RP   A2), AND MUTAGENESIS OF ARG-266.
RX   PubMed=24098712; DOI=10.1371/journal.pone.0075669;
RA   Friend L.R., Landsberg M.J., Nouwens A.S., Wei Y., Rothnagel J.A.,
RA   Smith R.;
RT   "Arginine methylation of hnRNP A2 does not directly govern its subcellular
RT   localization.";
RL   PLoS ONE 8:E75669-E75669(2013).
CC   -!- FUNCTION: Heterogeneous nuclear ribonucleoprotein (hnRNP) that
CC       associates with nascent pre-mRNAs, packaging them into hnRNP particles.
CC       The hnRNP particle arrangement on nascent hnRNA is non-random and
CC       sequence-dependent and serves to condense and stabilize the transcripts
CC       and minimize tangling and knotting. Packaging plays a role in various
CC       processes such as transcription, pre-mRNA processing, RNA nuclear
CC       export, subcellular location, mRNA translation and stability of mature
CC       mRNAs. Forms hnRNP particles with at least 20 other different hnRNP and
CC       heterogeneous nuclear RNA in the nucleus (PubMed:19099192). Involved in
CC       transport of specific mRNAs to the cytoplasm in oligodendrocytes and
CC       neurons: acts by specifically recognizing and binding the A2RE (21
CC       nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11
CC       nucleotide oligonucleotide) sequence motifs present on some mRNAs, and
CC       promotes their transport to the cytoplasm (PubMed:10567417,
CC       PubMed:9578590). Specifically binds single-stranded telomeric DNA
CC       sequences, protecting telomeric DNA repeat against endonuclease
CC       digestion (PubMed:15659580). Also binds other RNA molecules, such as
CC       primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-
CC       methyladenosine (m6A) mark by specifically recognizing and binding a
CC       subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing
CC       pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8
CC       to pri-miRNA transcripts. Involved in miRNA sorting into exosomes
CC       following sumoylation, possibly by binding (m6A)-containing pre-miRNAs.
CC       Acts as a regulator of efficiency of mRNA splicing, possibly by binding
CC       to m6A-containing pre-mRNAs. Plays a role in the splicing of pyruvate
CC       kinase PKM by binding repressively to sequences flanking PKM exon 9,
CC       inhibiting exon 9 inclusion and resulting in exon 10 inclusion and
CC       production of the PKM M2 isoform (By similarity). Also plays a role in
CC       the activation of the innate immune response. Mechanistically, senses
CC       the presence of viral DNA in the nucleus, homodimerizes and is
CC       demethylated by JMJD6. In turn, translocates to the cytoplasm where it
CC       activates the TBK1-IRF3 pathway, leading to interferon alpha/beta
CC       production (By similarity). {ECO:0000250|UniProtKB:P22626,
CC       ECO:0000269|PubMed:10567417, ECO:0000269|PubMed:15659580,
CC       ECO:0000269|PubMed:9578590, ECO:0000303|PubMed:19099192}.
CC   -!- SUBUNIT: Homodimer; dimerization is required for nucleocytoplasmic
CC       translocation. Identified in the spliceosome C complex. Identified in a
CC       IGF2BP1-dependent mRNP granule complex containing untranslated mRNAs.
CC       Interacts with IGF2BP1. Interacts with C9orf72. Interacts with DGCR8.
CC       Interacts with TARDBP. Interacts with CKAP5. Interacts with TBK1.
CC       Interacts with STING1. Interacts with SRC (By similarity). Interacts
CC       with PPIA/CYPA (By similarity). {ECO:0000250|UniProtKB:P22626}.
CC   -!- SUBCELLULAR LOCATION: [Isoform B1]: Nucleus
CC       {ECO:0000269|PubMed:20406423}.
CC   -!- SUBCELLULAR LOCATION: [Isoform A2]: Nucleus
CC       {ECO:0000269|PubMed:20406423, ECO:0000269|PubMed:24098712}.
CC   -!- SUBCELLULAR LOCATION: [Isoform A2b]: Cytoplasm
CC       {ECO:0000269|PubMed:20406423}. Nucleus {ECO:0000269|PubMed:20406423}.
CC       Note=Mainly localizes in the cytoplasm in neural cells.
CC       {ECO:0000269|PubMed:20406423}.
CC   -!- SUBCELLULAR LOCATION: [Isoform B1b]: Cytoplasm
CC       {ECO:0000269|PubMed:20406423}. Nucleus {ECO:0000269|PubMed:20406423}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P22626}. Nucleus,
CC       nucleoplasm {ECO:0000269|PubMed:9578590, ECO:0000269|PubMed:9925756}.
CC       Cytoplasm {ECO:0000269|PubMed:9925756}. Cytoplasmic granule
CC       {ECO:0000250|UniProtKB:P22626}. Secreted, extracellular exosome
CC       {ECO:0000250|UniProtKB:P22626}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs. Component of ribonucleosomes.
CC       Not found in the nucleolus. Found in exosomes following sumoylation.
CC       {ECO:0000250|UniProtKB:P22626}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.
CC         {ECO:0000269|PubMed:9925756};
CC       Name=B1 {ECO:0000303|PubMed:9925756};
CC         IsoId=A7VJC2-1; Sequence=Displayed;
CC       Name=A2 {ECO:0000303|PubMed:9925756};
CC         IsoId=A7VJC2-2; Sequence=VSP_053031;
CC       Name=A2b; Synonyms=B0a {ECO:0000303|PubMed:9925756};
CC         IsoId=A7VJC2-3; Sequence=VSP_053031, VSP_053032;
CC       Name=B1b; Synonyms=B0b {ECO:0000303|PubMed:9925756};
CC         IsoId=A7VJC2-4; Sequence=VSP_053032;
CC   -!- TISSUE SPECIFICITY: In the brain, isoform A2 and isoform B1 are
CC       abundant in large ganglion-type neurons, such as Purkinje cells, and
CC       are less abundant in neighboring glia cells. Isoform A2 is more
CC       abundant than isoform B1 in brain. In testis, isoform A2 and isoform B1
CC       are present in spermatogonia and spermatocytes, but not in spermatids
CC       or sperm. Isoform A2 is more abundant in the adrenal medulla than in
CC       the cortical cells. Isoform B1 is found in both adrenal medulla and
CC       cortical cells. Isoform A2 is more abundant than isoform B1 in the
CC       adrenal gland. Isoform A2 and isoform B1 are both detected in pancreas
CC       and kidney, and at lower levels in heart and lung. Isoform B1 is more
CC       abundant than isoform A2 in heart, lung and intestine (at protein
CC       level). Isoform A2b and isoform B1b are testis-specific.
CC       {ECO:0000269|PubMed:9925756}.
CC   -!- DOMAIN: The disordered region, when incubated at high concentration, is
CC       able to polymerize into labile, amyloid-like fibers and form cross-beta
CC       polymerization structures, probably driving the formation of hydrogels.
CC       In contrast to irreversible, pathogenic amyloids, the fibers
CC       polymerized from LC regions disassemble upon dilution. A number of
CC       evidence suggests that formation of cross-beta structures by LC regions
CC       mediate the formation of RNA granules, liquid-like droplets, and
CC       hydrogels. {ECO:0000250|UniProtKB:P22626}.
CC   -!- PTM: Asymmetric dimethylation at Arg-266 constitutes the major
CC       methylation site (PubMed:24098712). According to a report, methylation
CC       affects subcellular location and promotes nuclear localization
CC       (PubMed:10772824). According to another report, methylation at Arg-266
CC       does not influence nucleocytoplasmic shuttling (PubMed:24098712).
CC       {ECO:0000269|PubMed:10772824, ECO:0000269|PubMed:24098712}.
CC   -!- PTM: Sumoylated in exosomes, promoting miRNAs-binding.
CC       {ECO:0000250|UniProtKB:P22626}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB006815; BAF79675.1; -; mRNA.
DR   EMBL; AB006816; BAF79676.1; -; mRNA.
DR   EMBL; AB006817; BAF79677.1; -; mRNA.
DR   EMBL; AB006818; BAF79678.1; -; mRNA.
DR   RefSeq; NP_001098083.1; NM_001104613.1.
DR   AlphaFoldDB; A7VJC2; -.
DR   SMR; A7VJC2; -.
DR   BioGRID; 263391; 7.
DR   IntAct; A7VJC2; 7.
DR   MINT; A7VJC2; -.
DR   STRING; 10116.ENSRNOP00000015152; -.
DR   GlyGen; A7VJC2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; A7VJC2; -.
DR   PhosphoSitePlus; A7VJC2; -.
DR   SwissPalm; A7VJC2; -.
DR   jPOST; A7VJC2; -.
DR   PaxDb; 10116-ENSRNOP00000015152; -.
DR   PeptideAtlas; A7VJC2; -.
DR   GeneID; 362361; -.
DR   KEGG; rno:362361; -.
DR   UCSC; RGD:1310403; rat. [A7VJC2-1]
DR   AGR; RGD:1310403; -.
DR   CTD; 3181; -.
DR   RGD; 1310403; Hnrnpa2b1.
DR   eggNOG; KOG0118; Eukaryota.
DR   InParanoid; A7VJC2; -.
DR   OrthoDB; 3127428at2759; -.
DR   PhylomeDB; A7VJC2; -.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-RNO-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   PRO; PR:A7VJC2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0015030; C:Cajal body; IDA:BHF-UCL.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; ISO:RGD.
DR   GO; GO:0000785; C:chromatin; IDA:RGD.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0071598; C:neuronal ribonucleoprotein granule; IDA:RGD.
DR   GO; GO:0016363; C:nuclear matrix; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; ISO:RGD.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL.
DR   GO; GO:0098505; F:G-rich strand telomeric DNA binding; IDA:BHF-UCL.
DR   GO; GO:0035198; F:miRNA binding; ISS:UniProtKB.
DR   GO; GO:0140693; F:molecular condensate scaffold activity; ISO:RGD.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:1990715; F:mRNA CDS binding; IDA:RGD.
DR   GO; GO:1990247; F:N6-methyladenosine-containing RNA reader activity; ISS:UniProtKB.
DR   GO; GO:0097157; F:pre-mRNA intronic binding; ISO:RGD.
DR   GO; GO:0001069; F:regulatory region RNA binding; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; IDA:RGD.
DR   GO; GO:0043047; F:single-stranded telomeric DNA binding; IDA:UniProtKB.
DR   GO; GO:0044806; P:G-quadruplex DNA unwinding; IDA:BHF-UCL.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:1990428; P:miRNA transport; ISS:UniProtKB.
DR   GO; GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; ISO:RGD.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; ISS:UniProtKB.
DR   GO; GO:0051028; P:mRNA transport; IBA:GO_Central.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEP:RGD.
DR   GO; GO:1905663; P:positive regulation of telomerase RNA reverse transcriptase activity; IDA:BHF-UCL.
DR   GO; GO:1904358; P:positive regulation of telomere maintenance via telomere lengthening; IDA:BHF-UCL.
DR   GO; GO:0031053; P:primary miRNA processing; ISS:UniProtKB.
DR   GO; GO:0051385; P:response to mineralocorticoid; IEP:RGD.
DR   GO; GO:0050658; P:RNA transport; IMP:RGD.
DR   GO; GO:0016233; P:telomere capping; IDA:UniProtKB.
DR   CDD; cd12762; RRM1_hnRNPA2B1; 1.
DR   CDD; cd12581; RRM2_hnRNPA2B1; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR021662; HnRNPA1/A2_C.
DR   InterPro; IPR034486; hnRNPA2B1_RRM1.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR48026:SF13; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS A2_B1; 1.
DR   PANTHER; PTHR48026; HOMOLOGOUS TO DROSOPHILA SQD (SQUID) PROTEIN; 1.
DR   Pfam; PF11627; HnRNPA1_LC; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 2.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Isopeptide bond; Methylation; mRNA processing; mRNA splicing;
KW   mRNA transport; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ribonucleoprotein; RNA-binding; Secreted; Spliceosome; Transport;
KW   Ubl conjugation.
FT   CHAIN           1..353
FT                   /note="Heterogeneous nuclear ribonucleoproteins A2/B1"
FT                   /id="PRO_0000365101"
FT   DOMAIN          21..104
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          112..191
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          193..353
FT                   /note="Disordered"
FT                   /evidence="ECO:0000269|PubMed:24098712"
FT   REGION          308..347
FT                   /note="Nuclear targeting sequence"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOTIF           9..15
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:P22626, ECO:0000255"
FT   COMPBIAS        191..205
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:24098712"
FT   MOD_RES         4
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         38
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O88569"
FT   MOD_RES         85
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         104
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         140
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         159
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         168
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         173
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         176
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         203
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O88569"
FT   MOD_RES         203
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         203
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         213
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:O88569"
FT   MOD_RES         213
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         213
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         228
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         238
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         266
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:24098712"
FT   MOD_RES         266
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         325
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         331
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         347
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   MOD_RES         350
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        104
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        112
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        137
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        152
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        168
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        173
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   CROSSLNK        186
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P22626"
FT   VAR_SEQ         3..14
FT                   /note="Missing (in isoform A2 and isoform A2b)"
FT                   /evidence="ECO:0000303|PubMed:9925756"
FT                   /id="VSP_053031"
FT   VAR_SEQ         254..293
FT                   /note="Missing (in isoform A2b and isoform B1b)"
FT                   /evidence="ECO:0000303|PubMed:9925756"
FT                   /id="VSP_053032"
FT   MUTAGEN         266
FT                   /note="R->A: Decreased methylation. Does not affect
FT                   subcellular location."
FT                   /evidence="ECO:0000269|PubMed:24098712"
SQ   SEQUENCE   353 AA;  37478 MW;  1C2E7BA8C8E98D6E CRC64;
     MEKTLETVPL ERKKREKEQF RKLFIGGLSF ETTEESLRNY YEQWGKLTDC VVMRDPASKR
     SRGFGFVTFS SMAEVDAAMA ARPHSIDGRV VEPKRAVARE ESGKPGAHVT VKKLFVGGIK
     EDTEEHHLRD YFEEYGKIDT IEIITDRQSG KKRGFGFVTF DDHDPVDKIF LQKYHTINGH
     NAEVRKALSR QEMQEVQSSR SGRGGNFGFG DSRGGGGNFG PGPGSNFRGG SDGYGSGRGF
     GDGYNGYGGG PGGGNFGGSP GYGGGRGGYG GGGPGYGNQG GGYGGGYDNY GGGNYGSGNY
     NDFGNYNQQP SNYGPMKSGN FGGSRNMGGP YGGGNYGPGG SGGSGGYGGR SRY
//
